DS
DGX icon

David Shaw’s Quest Diagnostics DGX Stock Holding History

David Shaw’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,100
Closed -$469K – 3961
2020
Q3 		$469K Hold
4,100
– – ﹤0.01% 3260
2020
Q2 		$467K Buy
+4,100
New +$435K ﹤0.01% 3410
2017
Q4 		– Sell
-5,300
Closed -$496K – 3591
2017
Q3 		$496K Buy
+5,300
New +$563K ﹤0.01% 2912

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

David Shaw's DGX Position: Q2 2026 in Review

David Shaw reduced its Quest Diagnostics (DGX) stake by 97% in Q2 2026, selling an estimated $28M and leaving 4,814 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #3734.

David Shaw first reported a position in DGX in Q4 2013 and has held it in 44 quarters since. The position peaked at $66.5M in Q4 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • David Shaw held 4,814 shares of Quest Diagnostics worth $1.02M as of Q2 2026.
  • David Shaw sold 142,913 Quest Diagnostics shares in Q2 2026, an estimated $28M.
  • Quest Diagnostics made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3734 holding.
  • David Shaw first reported a position in Quest Diagnostics in Q4 2013 and has held it in 44 quarters since.
  • David Shaw's Quest Diagnostics position peaked at $66.5M in Q4 2021.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.